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1. Biology of regeneration
Regeneration means the re-growth of part of the affected or lost organs of the remaining tis-
sue. Animals can regenerate some organs, such as the liver. If a part of the liver is lost due to 
illness or injury, the liver grows back to its original size, but not in its original form.
Figure 1. The amphibian renewal preceding amphibian growth may offer hints to humans. After amputation, the 
wound heals to form the skin layer, and the underlying tissue undergoes a matrix reshaping, and cells in the region 
secrete soluble factors. The heterogeneous cell mass, blastema, is formed by the proliferation and migration of cells from 
neighboring tissues. Next, the blastema leads to the appearance of different new tissues that are spatially plastered to 
reconstruct the structure of the original limb (credit: Lina et al. [1]).
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Figure 2. A view of a eukaryotic gene, its control elements in the DNA and the proteins that guide the RNA polymerase 
to the correct starting point for transcription [3].
Different species have significant capabilities to regenerate parts of the body or whole organ-
ism after injury (Figure 1), but a thorough understanding of the molecular basis of regenera-
tion mechanisms will require detailed genomic resources.
2. Building blocks and matrix
2.1. Cells
Cells are building units of tissues and organs and tissues are the basic unit of function in the 
body. In general, cells secrete their own support materials and structures, which are called an 
extracellular matrix. This matrix, or scaffold, is supporting the cells; it also performs as a relay 
station for a number signaling molecules [2].
2.2. Messages/signals
Cells acquire messages through multiple sources that grow available from the local environ-
ment. Each signal can enhance or initiate a series of responses that decide what will happen to 
the cell. By understanding how individual cells react to signals, interact with their surround-
ing environment, and organize them into tissues and organisms, researchers can manipulate 
these processes to repair damaged tissue or even create new cells.
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In all organisms, a DNA-dependent RNA polymerase is performing the production of mRNA 
for protein synthesis or the various non-coding RNA molecules that are used in the cell. 
Transcriptional control is the main method to control what proteins (and nucleic acids) are 
produced in the cell, and in what amounts (Figure 2).
3. Stem cells and regeneration
Tissues in the human organism are generated, maintained, and repopulated by stem cells 
(Figure 3). These are specialized cells capable of cell renewal and can differentiate into differ-
ent cell types in the human body. Stem cells have several differentiation programs; therefore, 
they possess information to allow them to become any cell in the body or a restricted cell type 
with a specialized function. These abilities make stem cells extremely useful for biomedical 
applications and regenerative medicine and have become the main molecular tool for these 
purposes. Skeletal muscles have some ability to regenerate and form new muscle tissue, while 
cardiac muscle cells do not regenerate. However, new research suggests that cardiac stem 
cells may be coaxed into regenerating cardiac muscles with new medical strategies. Smooth 
muscle cells have the greatest ability to regenerate.
Questions about how and why tissue regeneration attracts the attention of countless biolo-
gists, medical engineers, and doctors. Renewable capacity varies widely across organs and 
organisms and a range of model systems with different technical features and innovation 
strategies are studied. Several key issues common to natural regeneration are receiving new 
attention from improved models and approaches, including identification of innovative 
Figure 3. Induced pluripotent stem cells (iPSCs) were first created from human cells in 2007. These are adult cells that 
have been genetically converted to an embryonic stem cell-like state [3].
Introductory Chapter: Concepts of Tissue Regeneration
http://dx.doi.org/10.5772/intechopen.76996
5
capacity; importance of stem cells, differentiation and differentiation; how regeneration sig-
nals begin and target; and mechanisms that control proliferation and renewed regeneration.
4. Regenerative medicine
Regenerative medicine is a new branch of medicine that tries to change the course of chronic 
diseases, and in many cases, regenerates organ systems that fail due to age, disease, damage, 
or genetic defects. The area has quickly become one of the promising treatment options for 
patients with tissue failure. It also includes tissue engineering, but also involves the search for 
self-healing—the body uses its own systems, sometimes with the help of foreign biological 
materials to reconstitute cells and rebuild tissues and organs. The terms “tissue engineering” 
and “regenerative medicine” have become highly interchangeable, with the field hoping to focus 
on treatments rather than complex and often chronic disease treatments.
Tissue engineering is an emerging biomedical field aimed at helping to restore physical 
tissue defects to the point of self-repair as well as replacing the biological functions of dam-
aged and injured members using cells with reproductive and differential abilities. In addi-
tion to basic research on these cells, there is no doubt that successful tissue engineering is 
indispensable for creating an artificial environment that enables cells to stimulate tissue 
regeneration. Such an environment can be achieved using scaffolds for cell proliferation, 
differentiation, and growth factors, as well as combining them. Growth factors are often 
required to promote tissue regeneration, as they can stimulate the formation of blood ves-
sels, which supply oxygen and nutrients to the transplanted cells to replace the organ to 
maintain its biological functions.
It requires functional platforms or scaffolds with specific properties concerning the morphol-
ogy, chemistry of the surface, and interconnectivity to promote cell adhesion and prolifera-
tion. These requisites are not only important for cellular migration but also to supply nutrients 
and expulsion of waste molecules. Cell type must be considered when designing of using a 
specific cellular grown system as scaffold; for instance, if they are autologous, allogeneic, or 
xenogeneic. The challenge in tissue engineering is to develop an organized three-dimensional 
architecture with functional characteristics that mimic the extracellular matrix. In this regard, 
with the advent of nanotechnology, scaffolds are now being developed that meet most of the 
requisites.
The technology of tissue engineering has evolved from the development of biological materi-
als (biomaterials) and refers to the practice of combining scaffolds, cells, and biologically active 
molecules of functional tissues. The aim of tissue engineering is to gather functional structures 
that restore, maintain, or improve damaged tissues or full organs. Artificial engineered skin 
and cartilage tissues are examples that have been recently authorized by the FDA [2].
The operation is usually initiated by building a scaffold from a wide range of potential sources, 
from proteins to plastics. When scaffolds are created, cells with or without a “mix” of growth 
factors can be introduced. Assuming that the environment is appropriate, the tissue grows. 
Sometimes, cells, scaffolds, and growth factors are mixed together simultaneously, giving the 
tissue the opportunity to “self-assemble” [2].
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Different ways to create a new fabric or tissue is using the present scaffold. The donor tissue 
or organ cells are stripped and the maintained collagen scaffold is used to form a new tissue. 
A new tissue has been created in the biological engineering of the heart, liver, lungs, and 
kidney tissues in rat. This approach holds great promise for the use of scaffolds from human 
tissues that are discarded during surgery and integrated with the patient’s own cells for the 
work of dedicated members that cannot be rejected by the immune system.
The tissue needs a good “draining and plumbing system” (veins or arteries), a way to feed 
nutrients into cells and carry waste. Without blood supply or any similar mechanism, cells die 
quickly. Ideally, scientists would like to be able to create engineered tissue using a plumbing 
system that has already been built (lattices). New hope for the bum knee: cartilage has been 
very difficult, if it is not impossible to repair since cartilage lacks a blood supply to promote 
regeneration. The gel/adhesive combo was successful in regenerating cartilage tissue follow-
ing surgery in a recent clinical trial of patients.
5. The main goal of tissue regeneration
The main goal of tissue regeneration studies is to acquire knowledge that will enhance the 
new wide range of regenerative medicine. This information may include evidence to stimu-
late stem cell activity, structural engineering of better scaffolds or direct initiation of biologic 
regeneration programs. Scientists already understand some forms of regeneration enough 
to manipulate and modify major events for therapeutic reasons. For example, the common 
practice of bone marrow transplantation is to properly guide hematopoietic cells to regener-
ated blood cells. However, for most examples of innovation, research has begun to acquire 
knowledge and techniques to try to ban or enhance selective steps selectively during renewal.
5.1. Musculoskeletal tissues
Musculoskeletal injuries impact millions of people globally and affect their health and 
well-being as well as of their companion and athletic animals. Soft-tissue injuries represent 
almost half of these and are associated with unorganized scar tissue formation and long time-
depending healing processes. Cell based therapeutic strategies have been developed in the 
past decades aiming at the treatment and reversion of such disorders. Stem cells are appeal-
ing in the field, being a responsive undifferentiated population, with ability to self-renew and 
differentiate into different lineages. Mesenchymal stem cells can be obtained from several 
adult tissues, including the synovial membrane. Synovia-derived mesenchymal stem cells 
can be found in individuals of any age and are associated to intrinsic regenerative processes, 
through both paracrine and cell-to-cell interactions, thus, contributing to host healing capac-
ity. Studies have demonstrated the potential benefit of synovia-derived mesenchymal stem 
cells in these regenerative processes in both human and veterinary medicine.
5.2. Bone regeneration
Bone regeneration is a surgical technique (Figure 4) that uses barrier membranes to direct, 
or guide, the growth of new bone at the site of the defect. The principle is that the barrier 
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membranes create and maintain a space above the bone defect; this allows the slower mesen-
chymal cells with osteogenic potential to populate the defect and regenerate without interfer-
ence from the more quickly proliferating overlying soft tissues. Protection of the clot in the 
defect, exclusion of gingival connective tissue cells, and preparation of an enclosed space in 
which osteogenic cells can migrate from the bone are three essential elements of a successful 
outcome. Many types of grafts have been used as space maintainers between the membrane 
and the bone defect. Autografts, allografts, and xenografts have all been used successfully, 
either alone or in combination, for bone regeneration using particulate materials.
5.3. Applications
Tissue engineering currently plays a relatively small role in treating patients. Additional blad-
der, small arteries, skin grafts, cartilage, and even the entire trachea have been implanted 
in patients but the operation is still experimental and of high cost. While the more complex 
organ tissues such as heart, lung, and hepatic tissue have been successfully reconstituted 
in the laboratory, they are far from being entirely cloned and ready for transplantation in a 
patient. These tissues, however, can be very useful in research, especially in drug research [2].
Researchers have developed multi-capacity (pluripotent) stem cells that can be transformed 
into any type of cell in different types of specific areas and found that they controlled by 
very specific gene networks that determine the fate of cells. Most other medical research has 
focused on multivariate stem cells to modify the range of growth solutions in which cells are 
placed. Bone marrow stem cells in mature cells have been able to take stem cells along the way 
from multiple-capacity to bone maturation that can be implanted in a patient.
The ability to regenerate a new kidney from a patient’s own cells would provide major relief 
for the hundreds of thousands of patients suffering from kidney disease. The resulting organ 
tissue was able to remove metabolites, re-absorb nutrients, and produce urine both in vitro 
and in vivo in rats. This process has been used previously in the heart, liver, and lung tissue. 
Figure 4. Bone scaffold: the bone capacity or the osteogenic potential of a bone graft is given by cells involved in bone 
formation, such as mesenchymal stem cells, osteoblasts, and osteocytes. The term osteoconductive refers to the scaffold 
or matrix which stimulates bone cells to grow on its surface [4].
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The development of implantable tissue to replace renal function permanently is a promising 
hope in overcoming donor deficiency problems and morbidity associated with immunosup-
pression in transplantation.
One of the main challenges researchers face when trying to cultivate tissue engineering organs 
is to produce a scaffold, in which new cells can be implanted. While some scientists have fol-
lowed three-dimensional printed scaffolds, many others focused on decellularization of local 
tissues to produce non-cellular scaffolds. The decellularization process typically consists of 
a series of perfused detergents through the organ, stripping the cells and nuclear material 
behind, and leaving the extracellular matrix. When developing decellularization protocols, 
researchers must balance the need for cellular material elimination with the need to maintain 
the properties of an extracellular matrix important.
Humans have limited regeneration ability, all the organ tissues can regrow, but it is very lim-
ited except the liver. Studies can find new methods to deal with regeneration. Recently, sci-
entists are investigating the genes and factors which are active during regeneration. Scientists 
already understand some forms of regeneration sufficiently to manipulate and modify key 
events for therapeutic causes. So, in future, people will not need to use prosthesis, it will be 
more comfortable than using prosthesis because limbs will not lose their function and the 
regeneration of disabled people.
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